TY - JOUR
T1 - The REALIST (REsiduAl risk, LIpids and Standard Therapies) study: An analysis of residual risk attributable to lipid profile in acute coronary syndrome.
AU - Millán Núnez-Cortes, Jesús
AU - Montoya, Juan Pedro Botet
AU - Salas, Xavier Pintó
AU - Mijares, Antonio Hernández
AU - Carey, Vincent J.
AU - Hermans, Michel P.
AU - Sacks, Frank M.
AU - Fruchart, Jean Charles
PY - 2011/1/1
Y1 - 2011/1/1
N2 - The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. © 2010 SEEN.
AB - The R3i Foundation (Residual Risk Reduction Initiative), an independent, multinational and academic organization, is conducting the REALIST (Residual Risk, Lipids and Standard Therapies) study in 40 centers in different countries. This is a retrospective epidemiological study, designed to provide new data on the residual risk of major coronary events attributable to lipid abnormalities in patients receiving the current standard treatment. The initial results are expected in mid 2010, and the overall results at the end of 2010. © 2010 SEEN.
KW - Dyslipidemia
KW - Ischemic heart disease
KW - Residual risk
U2 - 10.1016/j.endonu.2010.10.004
DO - 10.1016/j.endonu.2010.10.004
M3 - Article
VL - 58
SP - 38
EP - 47
JO - Endocrinologia, Diabetes y Nutricion
JF - Endocrinologia, Diabetes y Nutricion
SN - 2530-0164
IS - 1
ER -